| 151 |
9463023 | [Pharmacokinetics of hypoglycemic sulfonamides: Ozidia, a new concept]. | 1997 Nov |
1 |
| 152 |
15251771 | Effect of adding a sulfonylurea in patients with non-insulin-dependent diabetes mellitus previously well controlled with insulin. | 1997 Nov-Dec |
2 |
| 153 |
8773160 | Effects of aspirin and ibuprofen on the pharmacokinetics and pharmacodynamics of glyburide in healthy subjects. | 1996 Jan |
1 |
| 154 |
8842604 | Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas. | 1996 Aug |
1 |
| 155 |
8911981 | The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus. | 1996 Sep |
1 |
| 156 |
8960854 | NIDDM: a rapid progressive disease. Results from a long-term, randomised, comparative study of insulin or sulphonylurea treatment. | 1996 Dec |
1 |
| 157 |
9026680 | [Comparative study of the efficiency of ultralente insulin and NPH insulin combined with sulfonylurea in type 2 diabetes patients with secondary tolerance to sulfonylurea. Possible selection criteria]. | 1996 Jun |
1 |
| 158 |
9072666 | [Comparison of two treatment models in type-II diabetic patients with poor metabolic control: Preformed combination of glibenclamide 2,5 mg + metformin 400 mg or mono-therapy with sulfonylurea at maximal doses? An evaluation at six months]. | 1996 Sep |
1 |
| 159 |
7589855 | An ATP-sensitive Cl- channel current that is activated by cell swelling, cAMP, and glyburide in insulin-secreting cells. | 1995 Dec |
1 |
| 160 |
8846678 | More uniform diurnal blood glucose control and a reduction in daily insulin dosage on addition of glibenclamide to insulin in type 1 diabetes mellitus: role of enhanced insulin sensitivity. | 1995 Oct |
3 |
| 161 |
7988301 | Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans. | 1994 Sep |
3 |
| 162 |
8082525 | Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study. | 1994 Jun |
2 |
| 163 |
8112188 | Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide. Glycemic control and insulin secretion during 15 months. | 1994 Jan |
3 |
| 164 |
8123030 | Glyburide enhances insulin gene expression and glucose-induced insulin release in isolated rat islets. | 1994 Feb 28 |
6 |
| 165 |
8200602 | [Management of diabetes in general practice--current requirements. 2: Oral antidiabetics and insulin therapy]. | 1994 Apr 30 |
1 |
| 166 |
8201916 | [Houssay's phenomenon in man]. | 1993 |
2 |
| 167 |
8378743 | Does glibenclamide influence the clearance of insulin and glucose uptake in patients with type 2 diabetes mellitus? | 1993 Jul |
2 |
| 168 |
8403805 | Potassium channels in hypokalaemic periodic paralysis: a key to the pathogenesis? | 1993 Sep |
1 |
| 169 |
8454937 | Insulin and IGF1 receptor function among type II diabetic responders and nonresponders to glyburide. | 1993 Apr |
2 |
| 170 |
8511023 | Correction of hyperinsulinemia by glyburide treatment in nondiabetic patients with thalassemia major. | 1993 May |
4 |
| 171 |
1289019 | Morning or bed-time insulin with or without glibenclamide in elderly type 2 diabetic patients unresponsive to oral antidiabetic agents. | 1992 Dec |
1 |
| 172 |
1547684 | Combination therapy for NIDDM with biosynthetic human insulin and glyburide. | 1992 Feb |
5 |
| 173 |
1611155 | Treatment of type I diabetes with a combination of glyburide and insulin. | 1992 Jun |
3 |
| 174 |
1611644 | Glyburide in non-insulin-dependent diabetes: an update. | 1992 Mar-Apr |
4 |
| 175 |
1628875 | Potassium channels of the insulin-secreting B cell. | 1992 |
1 |
| 176 |
1660613 | Sulfonylurea signal transduction. | 1991 |
1 |
| 177 |
1847815 | Glyburide priming of beta cells. Possible involvement of phosphoinositide hydrolysis. | 1991 Mar 1 |
1 |
| 178 |
1902411 | Comparative effects of diet or glibenclamide on insulin secretion and action in non-obese NIDDM. | 1991 Feb |
1 |
| 179 |
1904820 | Extrapancreatic insulin effect of glibenclamide. | 1991 |
3 |
| 180 |
1908182 | Effects of sulfonylureas on adipocyte and skeletal muscle insulin action in patients with non-insulin-dependent diabetes mellitus. | 1991 Jun 24 |
1 |
| 181 |
1916009 | Complement activation via the alternative pathway in a patient with insulin-dependent diabetes mellitus. | 1991 Jul-Aug |
1 |
| 182 |
1954808 | Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans. | 1991 Aug |
1 |
| 183 |
2110711 | Comparative study of the therapeutic effects of glibenclamide or the fixed combination of glibenclamide-phenformin with those of gliclazide or chlorpropamide. | 1990 Jan-Mar |
1 |
| 184 |
2115686 | [Insulin-sulfonylurea combination therapy in secondary therapy failure with sulfonylurea compounds. Randomized study between evening and morning intermediary insulin administration using the Novo Pen semi-automatic insulin injector]. | 1990 Jul 10 |
1 |
| 185 |
2117385 | Effect of glyburide on beta cell responsiveness to glucose in non-insulin-dependent diabetes mellitus. | 1990 Aug 20 |
5 |
| 186 |
2117386 | Effects of glyburide on carbohydrate metabolism and insulin action in the liver. | 1990 Aug 20 |
4 |
| 187 |
2117387 | Effect of glyburide on hepatic glucose metabolism. | 1990 Aug 20 |
1 |
| 188 |
2117389 | Effects of glyburide on in vivo insulin-mediated glucose disposal. | 1990 Aug 20 |
3 |
| 189 |
2119677 | Lack of effect of tenoxicam on dynamic responses to concurrent oral doses of glucose and glibenclamide. | 1990 Aug |
1 |
| 190 |
2122177 | Skeletal muscle glycogen synthase activity in subjects with non-insulin-dependent diabetes mellitus after glyburide therapy. | 1990 Nov |
4 |
| 191 |
2123183 | Combination therapy of glibenclamide and insulin in NIDDM patients with secondary failure to oral drugs. | 1990 Aug |
1 |
| 192 |
2125460 | Betaxolol and glucose-insulin relationships: studies in normal subjects taking glibenclamide or metformin. | 1990 Nov |
1 |
| 193 |
2126639 | Combined insulin-glibenclamide therapy of NIDDM patients in primary health care. A follow-up study of its compliance and efficacy and a review of the literature. | 1990 Dec |
1 |
| 194 |
2171690 | Reduced glucose-6-phosphorylase and NADPH generating enzyme activities associated with glibenclamide induced hypoglycemia and hypoinsulinemia in genetically obese mice. | 1990 |
3 |
| 195 |
2499443 | Effects of combined insulin-sulfonylurea therapy in type II patients. | 1989 Jun |
1 |
| 196 |
2504288 | Effects of tolbutamide, glibenclamide and diazoxide upon action potentials recorded from rat ventricular muscle. | 1989 Aug 21 |
1 |
| 197 |
2505990 | Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide. | 1989 Sep |
1 |
| 198 |
2524334 | How does glibenclamide lower plasma glucose concentration in patients with type 2 diabetes? | 1989 May-Jun |
3 |
| 199 |
2559356 | Insulin and IGF-I receptors in neuroblastoma cells: increases in mRNA and binding produced by glyburide. | 1989 Oct |
1 |
| 200 |
3126291 | A system approach to pharmacodynamics. II: Glyburide pharmacodynamics and estimation of optimal drug delivery. | 1988 Jan |
1 |